Midwest Capital Advisors LLC Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Midwest Capital Advisors LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 104 shares of the medical equipment provider’s stock, valued at approximately $54,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth $26,000. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter worth $36,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Finally, Sierra Ocean LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth $40,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Evercore ISI raised their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 2.4 %

Shares of NASDAQ ISRG opened at $591.79 on Monday. The stock has a market cap of $210.78 billion, a PE ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business has a 50-day moving average price of $565.45 and a 200 day moving average price of $525.60.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.